Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Neurological Sciences

• Publication date

  1994-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0022-510X(94)90248-8PMID 7964895
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spectrophotometric assay of cytochrome c oxidase.

  2006cited by this paper
• ATP-sensitive potassium channels counteract anoxia in neurones of the substantia nigra

  2004cited by this paper
• Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients

  1993cited by this paper
• Mitochondrial involvement in Parkinson's disease: the controversy continues.

  1993cited by this paper
• Mitochondria1 involvement in Parkinson's disease

  1993cited by this paper
• Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease.

  1993cited by this paper
• Mitochondria1 respiratory chain activity in skeletal muscle from patients with Parkinson's disease

  1993cited by this paper
• No evidence for altered muscle mitochondrial function in Parkinson's disease.

  1993cited by this paper
• Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease.

  1992cited by this paper
• Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease

  1992cited by this paper
• Mitochondria and Ageing

  1992cited by this paper
• Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group.

  1992cited by this paper
• Mitochondrial oxidative phosphorylation defects in Parkinson's disease

  1992cited by this paper
• Uneven distribution of mitochondrial DNA mutation in MERRF dizygotic twins.

  1992cited by this paper
• Is Parkinson's disease a mitochondrial disorder?

  1992cited by this paper
• Platelet mitochondria function in Parkinson's disease

  1992cited by this paper
• L‐dopa does not affect electron transfer chain enzymes and respiration of rat muscle mitochondria

  1991cited by this paper
• Multiple defects of the mitochondrial respiratory chain in a mitochondrial encephalopathy (MERRF): a clinical, biochemical and molecular study.

  1991cited by this paper
• Mitochondrial oxidative phosphorylation defects in parkinson's disease

  1991cited by this paper
• Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease.

  1991cited by this paper
• Psychopharmacological evidence for a role of the ATP-sensitive potassium channel in the substantia nigra of the rat.

  1991cited by this paper
• Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease

  1990cited by this paper
• Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease.

  1990cited by this paper
• Mitochondrial function and parental sex effect in Huntington's disease.

  1990cited by this paper
• Mitochondrial function and parental sex effect in Huntington's disease

  1990cited by this paper
• Evidence for a defect in NADH

  1990cited by this paper
• Sulfonylurea binding sites associated with ATP-regulated K+ channels in the central nervous system: autoradiographic analysis of their distribution and ontogenesis, and of their localization in mutant mice cerebellum.

  1990cited by this paper
• Multiple defects of the respiratory chain including complex II in a family with myopathy and encephalopathy.

  1989cited by this paper
• Mitochondrial function in Parkinson's disease.

  1989cited by this paper
• Mitochondrial complex I deficiency in Parkinson's disease.

  1989cited by this paper
• Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

  1989cited by this paper
• Abnormalities of the electron transport chain in idiopathic parkinson's disease

  1989cited by this paper
• Multiple system atrophy--the nature of the beast.

  1989cited by this paper
• Liver mitochondrial respiratory functions decline with age.

  1989cited by this paper
• Mitochondrial Complex I Deficiency in Parkinson's Disease

  1989cited by this paper
• On the mechanism of the Mn3(+)-induced neurotoxicity of dopamine:prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase.

  1989cited by this paper
• Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing.

  1989cited by this paper
• Methods for study of normal and abnormal skeletal muscle mitochondria.

  1988cited by this paper
• Increased nigral iron content in postmortem parkinsonian brain.

  1987cited by this paper
• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

  1985cited by this paper
• PRIMARY DEPRESSION OR PRIMARY ANXIETY? A POSSIBLE PSYCHOMETRIC APPROACH TO A DIAGNOSTIC DILEMMA

  1984cited by this paper
• Assessment of Parkinson's Disease

  1984cited by this paper
• Medicine and the law. Consent to medical treatment in prison.

  1983cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper
• The metabolism of menadione impairs the ability of rat liver mitochondria to take up and retain calcium.

  1982cited by this paper
• [47] Mammalian succinate dehydrogenase

  1978cited by this paper
• Mammalian succinate dehydrogenase.

  1978cited by this paper
• Letter: Cancer detection.

  1976cited by this paper
• Milk antibodies and myocardial infarction [Letter]

  1974cited by this paper
• [2] Citrate synthase from rat liver: [EC 4.1.3.7 Citrate oxaloacetage-lyase (CoA-acetylating)]

  1969cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Mitochondrial Ultrastructure, Fission Proteins, Activity, and Motor Dysfunctions in the Innovative Parkinson’s Disease Model Induced by Manganese Inhalation

  2026cites this paper
• Idebenone alleviates rotenone-induced mitochondrial dysfunction through mitophagy and mitochondrial biogenesis in muscle cells.

  2025cites this paper
• Mitochondrial complex I deficiency occurs in skeletal muscle of a subgroup of individuals with Parkinson’s disease

  2025cites this paper
• Ultrasound elastography in the assessment of rigidity in Parkinson's disease: A scoping review.

  2025cites this paper
• Revisiting the Mitochondrial Function and Communication in Neurodegenerative Diseases.

  2024cites this paper
• Probing the diagnostic values of plasma cf-nDNA and cf-mtDNA for Parkinson’s disease and multiple system atrophy

  2024cites this paper
• The Role of Muscle Strength in the Sit-to-Stand Task in Parkinson's Disease

  2023cites this paper
• Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease.

  2023cites this paper
• Mitochondrial Dysfunction in Skeletal Muscle of Rotenone-Induced Rat Model of Parkinson’s Disease: SC-Nanophytosomes as Therapeutic Approach

  2023cites this paper
• Role of Oligodendrocyte Lineage Cells in Multiple System Atrophy

  2023cites this paper
• Coenzyme Q10: A Biomarker in the Differential Diagnosis of Parkinsonian Syndromes

  2023cites this paper
• The Impact of microRNAs on Mitochondrial Function and Immunity: Relevance to Parkinson’s Disease

  2023cites this paper
• Impaired skeletal muscle health in Parkinsonian syndromes: clinical implications, mechanisms and potential treatments

  2023influential citation
• NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson’s Disease

  2022cites this paper
• Hallmarks and Molecular Tools for the Study of Mitophagy in Parkinson’s Disease

  2022cites this paper
• Endurance exercise training suppresses myostatin upregulation and nuclear factor-kappa B activation in a mouse model of Parkinson’s disease

  2022cites this paper
• α‐Synuclein aggregation causes muscle atrophy through neuromuscular junction degeneration

  2022cites this paper
• Mangosteen Pericarp Extract Supplementation Boosts Antioxidant Status via Rebuilding Gut Microbiota to Attenuate Motor Deficit in 6-OHDA-Induced Parkinson’s Disease

  2022cites this paper
• Title: Heterocyclic aromatic amines (HAAs) target mitochondrial physiology

  2022cites this paper
• Heterocyclic aromatic amines (HAAs) target mitochondrial physiology

  2022cites this paper
• Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson’s disease? A critical reappraisal

  2021influential citation
• Understanding the Multiple Role of Mitochondria in Parkinson’s Disease and Related Disorders: Lesson From Genetics and Protein–Interaction Network

  2021cites this paper
• Impaired mitochondrial functions and energy metabolism in MPTP-induced Parkinson’s disease: comparison of mice strains and dose regimens

  2021cites this paper
• Mitophagy in sarcopenic muscle and practical recommendations for exercise training

  2021cites this paper
• Nuclear and Mitochondrial Genome, Epigenome and Gut Microbiome: Emerging Molecular Biomarkers for Parkinson’s Disease

  2021cites this paper
• Importance of Mitochondrial Quality Control in Parkinson’s Disease: The Potential Interplay of Mitochondrial Unfolded Protein Response and Mitophagy

  2021cites this paper
• The Proper Diet and Regular Physical Activity Slow Down the Development of Parkinson Disease

  2021cites this paper
• The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease

  2020cites this paper
• Coenzyme Q and Age-Related Neurodegenerative Disorders: Parkinson and Alzheimer Diseases

  2020cites this paper
• Coenzyme Q in Aging

  2020cites this paper
• A Ketone Ester Drink Enhances Endurance Exercise Performance in Parkinson’s Disease

  2020cites this paper
• Shared Genetics of Multiple System Atrophy and Inflammatory Bowel Disease

  2020influential citation
• Brain and Muscle: How Central Nervous System Disorders Can Modify the Skeletal Muscle

  2020cites this paper
• Fatigability and Cardiorespiratory Impairments in Parkinson’s Disease: Potential Non-Motor Barriers to Activity Performance

  2020cites this paper
• Mechanisms of alpha-synuclein toxicity: An update and outlook.

  2020cites this paper
• Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA

  2020cites this paper
• The feasibility of muscle mitochondrial respiratory chain phenotyping across the cognitive spectrum in Parkinson's disease.

  2020cites this paper
• NF-κB-Mediated Neuroinflammation in Parkinson’s Disease and Potential Therapeutic Effect of Polyphenols

  2019cites this paper
• A genome-wide genetic pleiotropy approach identified shared loci between multiple system atrophy and inflammatory bowel disease

  2019cites this paper
• Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges

  2019cites this paper
• The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

  2019cites this paper
• Mitochondrial Proteins in the Development of Parkinson's Disease.

  2019cites this paper
• Non-Cell Autonomous Mechanism of Parkinson's Disease Pathology Caused by G2019S LRRK2 Mutation in Ashkenazi Jewish Patient: Single Cell Analysis.

  2019cites this paper
• Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease

  2019cites this paper
• Cytosolic Trapping of a Mi tochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies Graphical

  2019cites this paper
• FTY720-mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in multiple system atrophy mice.

  2019cites this paper
• Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies.

  2019cites this paper
• Understanding the pathogenesis of multiple system atrophy: state of the art and future perspectives

  2019cites this paper
• Alpha-Synuclein Toxicity is Caused by Mitochondrial Dysfunction

  2019cites this paper
• Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease

  2018cites this paper
• Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review).

  2018cites this paper
• Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders

  2018cites this paper
• Riboflavin in Human Health: A Review of Current Evidences.

  2018cites this paper
• Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson’s Disease

  2018cites this paper
• Loss of Parkin impairs mitochondrial function and leads to muscle atrophy.

  2018cites this paper
• Aerobic rehabilitation program for improving muscle function in Parkinson’s disease

  2018cites this paper
• DNA versus RNA oxidation in Parkinson's disease: Which is more important?

  2018cites this paper
• Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy.

  2018cites this paper
• Selective basal ganglia vulnerability to energy deprivation: Experimental and clinical evidences

  2018cites this paper
• Current perspective of mitochondrial biology in Parkinson's disease.

  2018cites this paper
• Dietary Phytochemicals in Neurodegenerative Disease

  2017cites this paper
• Increased energy expenditure during posture maintenance and exercise in early Parkinson disease

  2017cites this paper
• Can a Smartphone Diagnose Parkinson Disease? A Deep Neural Network Method and Telediagnosis System Implementation

  2017cites this paper
• Short-term succinic acid treatment mitigates cerebellar mitochondrial OXPHOS dysfunction, neurodegeneration and ataxia in a Purkinje-specific spinocerebellar ataxia type 1 (SCA1) mouse model

  2017cites this paper
• Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer’s disease and Parkinson’s disease

  2017cites this paper
• Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson’s Disease?

  2017cites this paper
• Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease

  2017cites this paper
• Oxidative Stress: Mechanistic Insights into Inherited Mitochondrial Disorders and Parkinson’s Disease

  2017cites this paper
• Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer’s disease and Parkinson’s disease

  2017cites this paper
• Neuroprotective effect of treadmill exercise possibly via regulation of lysosomal degradation molecules in mice with pharmacologically induced Parkinson’s disease

  2017cites this paper
• Mitochondrial Mechanisms of Degeneration and Repair in Parkinson's Disease

  2016cites this paper
• Mitochondrial control of cell bioenergetics in Parkinson's disease.

  2016cites this paper
• Toxin-Mediated Complex I Inhibition and Parkinson’s Disease

  2016cites this paper
• THE EFFECT OF 3 DIFFERENT TRAINING PATTERNS ON THE MUSCLE STRENGTH OF PARKINSONION RATS INDUCED BY 6-HYDROXYDOPAMINE

  2016cites this paper
• Rotenone Susceptibility Phenotype in Olfactory Derived Patient Cells as a Model of Idiopathic Parkinson’s Disease

  2016cites this paper
• Neuropathological characterization of FL-PGC-1α-deficient mice – implications for mitochondrial encephalopathy

  2016cites this paper
• Blunted Maximal and Submaximal Responses to Cardiopulmonary Exercise Tests in Patients With Parkinson Disease.

  2016cites this paper
• Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation

  2016cites this paper
• Agrochemicals-Induced Dopaminergic Neurotoxicity: Role of Mitochondria-Mediated Oxidative Stress and Protein Clearance Mechanisms

  2015cites this paper
• Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses

  2015cites this paper
• Novel MRI Approaches to the Detection and Evaluation of Neurodegenerative Disease

  2015cites this paper
• Oxidative stress and Parkinson’s disease

  2015cites this paper
• Mitoconfusion: noncanonical functioning of dynamism factors in static mitochondria of the heart.

  2015cites this paper
• Critical Illness Neuromyopathy Complicating Akinetic Crisis in Parkinsonism

  2015cites this paper
• Stimulation of electron transport as potential novel therapy in Parkinson's disease with mitochondrial dysfunction.

  2015cites this paper
• Molecular characterization of the Parkinson's associated protein DJ-1

  2015cites this paper
• Large‐scale mitochondrial DNA deletion underlying familial multiple system atrophy of the cerebellar subtype

  2015cites this paper
• Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics

  2015cites this paper
• , capacity in individuals with Parkinson ' s disease muscle mass , mitochondrial function , and physical Novel , high-intensity exercise prescription improves

  2014cites this paper
• Rôle de la dysfonction mitochondriale dans deux maladies neurodégénératives, la Maladie de Huntington et la Maladie de Parkinson

  2014cites this paper
• Coenzyme Q10 in neurodegenerative disorders: Potential benefit of CoQ10 supplementation for multiple system atrophy

  2014cites this paper
• Skeletal muscle mitochondria: a major player in exercise, health and disease.

  2014cites this paper
• An update on the cerebellar subtype of multiple system atrophy

  2014influential citation
• Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease.

  2014cites this paper
• A phenotypic model recapitulating the neuropathology of Parkinson's disease

  2013cites this paper
• A matter of life, death and diseases: mitochondria from a proteomic perspective

  2013cites this paper
• Mitochondrial diseases of the brain.

  2013cites this paper
• Impact of Repeated Stress on Traumatic Brain Injury-Induced Mitochondrial Electron Transport Chain Expression and Behavioral Responses in Rats

  2013cites this paper
• The Impact of Mitochondrial DNA and Nuclear Genes Related to Mitochondrial Functioning on the Risk of Parkinson’s Disease

  2013cites this paper
• Mutations in COQ2 in familial and sporadic multiple-system atrophy.

  2013cites this paper